Open | $16.000 |
Close | $15.770 |
Volume / Avg. | 655.482K / 1.305M |
Day Range | 15.700 - 16.100 |
52 Wk Range | 8.000 - 17.240 |
Market Cap | $1.428B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 9.86% |
Days to Cover | 9.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avadel Pharmaceuticals (NASDAQ: AVDL) through any online brokerage.
Other companies in Avadel Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Avadel Pharmaceuticals (NASDAQ: AVDL) was reported by Craig-Hallum on Tuesday, March 5, 2024. The analyst firm set a price target for 22.00 expecting AVDL to rise to within 12 months (a possible 39.51% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Avadel Pharmaceuticals (NASDAQ: AVDL) is $15.77 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Avadel Pharmaceuticals.
Avadel Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Avadel Pharmaceuticals.
Avadel Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.